Poster Walk - DAA Treatment Therapies
Thursday, August 10, 2017 |
1:15 PM - 1:45 PM |
Exhibition/Grand Ballroom |
Speaker
Professor James O'Beirne
Staff Specialist
Sunshine Coast University Hospital
Maximising Access To Hepatitis C (Hcv) Treatment - The Sunshine Coast Experience
1:15 PM - 1:20 PMBiography
Prof. O'Beirne trained in Hepatology at the Royal Free and King's College Hospitals. London UK. He was appointed as Consultant Hepatologist and Transplant Physician at the Royal Free in 2007 until he joined the Hepatology service at the new Sunshine Coast University Hospital in 2017.
Stuart Roberts
SOF/VEL/VOX for 8 or 12 weeks achieves high SVR12 rates: an integrated analysis of the POLARIS-1, POLARIS-2, POLARIS-3, POLARIS-4 studies
1:23 PM - 1:28 PMBiography
Professor Roberts is Director of Hepatology at the Alfred Hospital, Melbourne. His areas of expertise include endoscopy and hepatology, particularly autoimmune and viral hepatitis. He is a member of the Gastroenterology Society of Australia, the Australian Liver Association and the European Association for the Study of the Liver.
Dr Nick Scott
Econometrician
Burnet Institute
Reaching Hepatitis C Virus Elimination Targets Requires Health System Interventions To Enhance The Care Cascade
1:30 PM - 1:35 PMBiography
Dr Nick Scott is an Econometrician at the Burnet Institute in Melbourne. He uses mathematical and economic models to inform policy in order to improve the health of vulnerable populations.
A/Prof Simone Strasser
Senior Staff Specialist
Royal Prince Alfred Hospital, Sydney
High SVR Rates With Eight And Twelve Weeks Of Pangenotypic Glecaprevir/Pibrentasvir: Integrated Efficacy And Safety Analysis Of Genotype 1-6 Patients Without Cirrhosis
1:38 PM - 1:43 PMBiography
Simone Strasser is Senior Staff Specialist and Director of Hepatology Clinical Trials at RPA Hospital in Sydney. She is a board member and honorary treasurer of GESA, a regular speaker in educational programs for health care workers and sits on multiple educational, advisory and administrative committees in Australia and internationally.
Discussant
David Iser
Director
Scope Gastroenterology